Tech Company Financing Transactions
Big Picture Bio Funding Round
Exceptional Ventures, Kadmos Capital and private investors participated in a $2 million funding round for Big Picture Bio. The round was announced on 9/24/2026.
Transaction Overview
Company Name
Announced On
9/24/2026
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
C/O Deep Science Ventures, 46-54 High Street
Ingatestone, Essex, CM4 9DW
UK
Ingatestone, Essex, CM4 9DW
UK
Phone
Undisclosed
Website
Email Address
Overview
Drug discovery is organised around finding one target that works on its own. Biology is not built that way. Biology runs on redundancy and feedback, so blocking one route very often means the cell reroutes through another. That is the core problem in cancer resistance and regrowth, and it applies across complex evolving diseases more widely, in immune disease, in neurological disease, and where the two intersect.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kerstin Papenfuss
Chief Technical Officer
Mark Hammond
Browse more venture capital transactions:
Prev: 9/24/2026: 50skills venture capital transaction
Next: 9/24/2026: Island venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs